<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02693054</url>
  </required_header>
  <id_info>
    <org_study_id>HALOCIP001</org_study_id>
    <nct_id>NCT02693054</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study for Various Skin Conditions</brief_title>
  <official_title>Characterizing Safety and Efficacy of Halo Hybrid Fractional Laser Treatments for Various Skin Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sciton</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sciton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Characterizing safety and efficacy of Halo Laser Treatment for Various Skin Conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to demonstrate safety and efficacy of Halo treatment as measured
      by changes in skin tone, texture and pigment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in skin conditions assessed by photographs</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of photographs by blinded evaluators</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction post final treatment</measure>
    <time_frame>3 months</time_frame>
    <description>Assessment of subject satisfaction with treatment result using survey/questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Dyschromia</condition>
  <condition>Photodamaged Skin</condition>
  <arm_group>
    <arm_group_label>Hybrid Fractional Laser Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Halo (1470nm and 2940 nm) laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HALO</intervention_name>
    <description>Laser Treatment</description>
    <arm_group_label>Hybrid Fractional Laser Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fitzpatrick Skin types I to IV

          -  Desires improvement of significant skin conditions on the face and/or neck

          -  Willingness to participate in the study by signing an informed consent form

          -  Will have limited sun exposure for at least two weeks prior to study screening and
             during the study, including the follow-up period

          -  Able to adhere to the treatment and follow-up schedule and post-treatment care
             instructions

          -  Post-menopausal or surgically sterilized female subjects.

        Exclusion Criteria:

          -  History of Halo or resurfacing procedures in the treatment area within past six months

          -  Has tanned within the past thirty days or unable or unlikely to refrain from tanning,
             including the use of tanning booths, tanning spray, or cream

          -  Has tattoos, dysplastic nevi in the treatment area

          -  Pregnant and/or lactating

          -  Is planning to get pregnant within the study period

          -  Has a known history of photosensitivity

          -  Has used medication with photosensitizing properties within the past six months, e.g.
             isotretinoin

          -  History or evidence of chronic or recurring skin disease or disorder (e.g. psoriasis,
             --Netherton syndrome, etc.) affecting the treatment area

          -  Has open lacerations, abrasions, active cold sores, or herpes sores

          -  Has hormonal disorders

          -  History of keloid or hypertrophic scar formation or poor wound healing

          -  History of immunosuppression or immune deficiency disorder (including HIV infection or
             AIDS) or use of immunosuppressive medications

          -  History of bleeding disorder or taking anticoagulation medications

          -  History of skin cancer or any other cancer in the treatment area

          -  Has significant concurrent illnesses, such as diabetes, lupus, epilepsy, or cardiac
             disorders, which might be aggravated as a result of treatment

          -  Has participated in any clinical trial involving an investigational drug or cosmetic
             product or procedure within the past thirty days

          -  The investigator feels that for any reason the subject is not eligible to participate
             in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Pozner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanctuary Plastic Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Robb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skin and Allergy Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth Tanzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Capital Laser and Skin Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jill Waibel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Miami Dermatology and Laser Institute</affiliation>
  </overall_official>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2016</study_first_submitted>
  <study_first_submitted_qc>February 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2016</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

